Scenario of Over the Counter Medicines Worldwide
Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 1
Abstract
Over the counter (OTC) drugs are medicines sold directly to consumer without any prescription. The OTC drug market in India is expected to grow by $6.6 billion by 2016 with Pharmaceutical companies and chemists increasing their presence in rural market. The market share of hospitals is expected to increase from 1.3% in 2009 to 26% in 2020. Also the Health Ministry has banned 344 fixed drugs combinations through a gazette notification issued over the weekend March, 2016. These include several cough syrup solutions, analgesics and antibiotic combinations and in which many of are sold over the counter. There is list of banned drugs which include Nimesulide which had been a cause for long for health experts for includes for its continued use in India despite being banned in most of the developed nations. Some of banned drug combinations are: a) Nimesulide + Diclofenac B) Diclofenac + Tramadol + Paracetamol C) Heparin + Diclofenac D) Azithromycin + Cefixime E) Telmisartan + Metformin and many more. Also India‟s OTC drug market stood at $3 billion in 2011 and a rise to $6.6 billion is forecast by 2016 according to sectoral document for pharmaceuticals industry. And in future India is known and expected to rank amongst top three pharmaceutical markets in terms of incremental growth by 2020.
Authors and Affiliations
Sunny Panwar, Khushboo Bhatia, Amrish Chandra
Keywords
Related Articles
- EP ID EP499251
- DOI 10.22270/ijdra.v7i1.308
- Views 111
- Downloads 0
Understanding the globally harmonized system of classification and Labeling of Chemicals-The Purple Book
Global Harmonized System (GHS), relating to hazard chemicals, is a process of making a regulation among countries uniform to the extent possible so as to benefit an industry to export its products to several countries wi...
FORMULATION AND EVALUATION OF SOLID DISPERSION OF TADALAFIL
Tadalafil is used for the treatment of the erectile dysfunction (ED) and pulmonary arterial hypertension. It is having low aqueous solubility thus it shows poor bioavailability of about 28% by after oral administration....
COMPARATIVE STUDY OF REGULATORY REQUIREMENTS AND REGISTRATION PROCESS OF GENERIC DRUGS IN JAPAN AND CHINA
A Generic Product must meet the standards established by Pharmaceutical Medical Device Agency (PMDA) & China Food and Drug Administration (CFDA) to be approved for marketing in Japan and China respectively. This study co...
GLOBAL REGULATORY APPROACH TOWARDS M-HEALTH
The past decade has witnessed rapid advancement in telecommunication and computer technologies. The smart phone is one result of that technological development and has been adopted by hundreds of millions of people world...
SYNTHESIS AND CHARACTERIZATION OF A NOVEL BONE GRAFT MATERIAL CONTAINING BIPHASIC CALCIUM PHOSPHATE AND CHITOSAN FORTIFIED WITH ALOE VERA
The bone grafts were prepared using nanohydroxyapatite (nanoHAP) with the extracts of AV and mixed with beta tricalcium phosphate (βTCP) in a ratio of 60:40. The formed BCP was then conjugated with CH to form the bone gr...